Threshold Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development of tumor-targeted medicines to improve the lives of individuals with cancer.

Latest News

November 15, 2016
Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2016

October 25, 2016
Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting System in the Development Program for Evofosfamide

September 29, 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities

View all news releases


November 16, 2016
Stifel 2016 Healthcare Conference
New York, NY

View All Events